The Efficacy of Fimasartan for Cardiovascular Events and Metabolic Syndrome (K-MetS Study): Rationale, Design and Participant Characteristics

Publisher： Karger

E-ISSN： 2235-8668|1|3-4|177-185

ISSN： 2235-8676

Source： Pulse, Vol.1, Iss.3-4, 2014-04, pp. : 177-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rationale and Design of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study

By  

Cerebrovascular Diseases, Vol. 27, Iss. 3, 2009-05 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

The Danish Alzheimer Intervention Study: Rationale, Study Design and Baseline Characteristics of the Cohort

By  

Neuroepidemiology, Vol. 36, Iss. 1, 2010-12 ,pp. : 52-61

Karger

Access to resources Recommend Favorite

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design

By MANN JESSICA   JULIUS STEVO  

Blood Pressure, Vol. 7, Iss. 3, 1998-08 ,pp. : 176-183

Informa Healthcare

Access to resources Recommend Favorite

The Metabolic Syndrome and Cardiovascular Risk

By  

Current Diabetes Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 137-143

Bentham Science Publishers

Access to resources Recommend Favorite

Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long‐tErm follow‐uP of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia)

By  

Clinical Cardiology, Vol. 160-9289, Iss. 9, 2015-09 ,pp. : 511-519

John Wiley & Sons Inc

Access to resources Recommend Favorite